Work

594: Abiraterone Acetate, an Oral Irreversible Inhibitor of CYP450C17, Administered to Castration Refractory Prostate Cancer Patients is Safe, Suppresses Androgen and Steroid Precursor Levels, and has a High Degree of Durable Antitumor Activity

Year: 2007

Type: conference-abstract

Source: The Journal of Urology

DOI: 10.1016/s0022-5347(18)30834-6

Authors: Timothy A. Yap, Gerhardt Attard, Alison Reid, Sarah Settatree, Christopher Parker, Mary Barrett, Florence Raynaud, Elizabeth Folkerd, Mitch Dowsett, Colin Cooper, David Deamaley, Johann S. de Bono

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2795312823

Cites:

Cited by: 1

Related to: 10